Literature DB >> 15100204

Glucose metabolism and coronary heart disease in patients with normal glucose tolerance.

Ferdinando C Sasso1, Ornella Carbonara, Rodolfo Nasti, Biagio Campana, Raffaele Marfella, Michele Torella, Giannantonio Nappi, Roberto Torella, Domenico Cozzolino.   

Abstract

CONTEXT: Several investigations as well as prospective studies have shown a significant correlation between glucose metabolism and atherosclerosis in patients without diabetes, but differences in parameters of glucose metabolism among the various degrees of coronary disease in such patients have not been specifically evaluated.
OBJECTIVE: To investigate glucose metabolism in patients with normal glucose tolerance (NGT) and coronary heart disease (CHD). DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional study of 234 men (mean [SD] age, 56.2 [6.1] years) with NGT and suspected CHD who were admitted from January 1 through June 30, 2001, to an academic medical center in Italy for coronary angiography. MAIN OUTCOME MEASURES: Correlation of glucose metabolic factors and extent of atherosclerosis determined by coronary angiography. Factors included levels of fasting and postload glucose and insulin, glycosylated hemoglobin (HbA1c), and lipids, as well as insulin resistance measured by homeostasis model assessment (HOMA-IR).
RESULTS: Patients were divided into 4 groups based on coronary angiography: no significant stenosis (n = 42), 1-vessel disease (n = 72), 2-vessel disease (n = 64), and 3-vessel disease (n = 56). Simple correlation analysis showed that the factors correlated with the extent of atherosclerosis were levels of postload glucose (r = 0.667), HbA1c (r = 0.561), postload insulin (r = 0.221), and fasting insulin (r = 0.297), as well as HOMA-IR (r = 0.278) (P<.001 for all). Multiple stepwise regression analysis suggested that the factors independently associated with the number of stenosed coronary arteries were levels of postload plasma glucose (r = 0.572), HbA1c (r = 0.413), postload insulin (r = 0.267), and fasting insulin (r = 0.174), as well as HOMA-IR (r = 0.250) (P<.001 for all). Similar results were obtained after grouping patients by Duke Myocardial Jeopardy Score.
CONCLUSIONS: For patients with NGT and different extents of atherosclerotic disease, postload glycemia and HbA1c level are not equally distributed but are significantly higher in those with more severe disease. This suggests that the glycemic milieu correlates with the cardiovascular risk according to a linear model.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15100204     DOI: 10.1001/jama.291.15.1857

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  21 in total

1.  Effects of Exercise in the Fasted and Postprandial State on Interstitial Glucose in Hyperglycemic Individuals.

Authors:  Håvard Nygaard; Bent R Rønnestad; Daniel Hammarström; Gerd Holmboe-Ottesen; Arne T Høstmark
Journal:  J Sports Sci Med       Date:  2017-06-01       Impact factor: 2.988

2.  Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease.

Authors:  Ruth McPherson; Jiri Frohlich; George Fodor; Jacques Genest
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

3.  Suppression of HDAC by sodium acetate rectifies cardiac metabolic disturbance in streptozotocin-nicotinamide-induced diabetic rats.

Authors:  Kehinde S Olaniyi; Oluwatobi A Amusa; Emmanuel D Areola; Lawrence A Olatunji
Journal:  Exp Biol Med (Maywood)       Date:  2020-03-17

4.  High prevalence of undiagnosed impaired glucose regulation and diabetes mellitus in patients scheduled for an elective coronary angiography.

Authors:  M Lankisch; R Füth; D Schotes; B Rose; H Lapp; W Rathmann; B Haastert; H Gülker; W A Scherbaum; Stephan Martin
Journal:  Clin Res Cardiol       Date:  2006-01-16       Impact factor: 5.460

Review 5.  The renin angiotensin aldosterone system and insulin resistance in humans.

Authors:  Patricia C Underwood; Gail K Adler
Journal:  Curr Hypertens Rep       Date:  2013-02       Impact factor: 5.369

Review 6.  Cellular metabolic and autophagic pathways: traffic control by redox signaling.

Authors:  Matthew Dodson; Victor Darley-Usmar; Jianhua Zhang
Journal:  Free Radic Biol Med       Date:  2013-05-20       Impact factor: 7.376

7.  Metabolomic profiling reveals distinct patterns of tricarboxylic acid disorders in blood stasis syndrome associated with coronary heart disease.

Authors:  Yong Wang; Chun Li; Hong Chang; Ling-Hui Lu; Qi Qiu; Yu-Lin Ouyang; Jun-da Yu; Shu-Zhen Guo; Jing Han; Wei Wang
Journal:  Chin J Integr Med       Date:  2016-05-16       Impact factor: 1.978

8.  Association of glucose measures with total and coronary heart disease mortality: does the effect change with time? The Rancho Bernardo Study.

Authors:  Beth E Cohen; Elizabeth Barrett-Connor; Christina L Wassel; Alka M Kanaya
Journal:  Diabetes Res Clin Pract       Date:  2009-08-09       Impact factor: 5.602

9.  Relationship between true fasting plasma insulin level and angiographic characteristics of coronary atherosclerosis.

Authors:  En-Zhi Jia; Zhi-Jian Yang; Biao Yuan; Xiao-Ling Zang; Rong-Hu Wang; Tie-Bing Zhu; Lian-Sheng Wang; B O Chen; Ke-Jiang Cao; Jun Huang; Wen-Zhu Ma
Journal:  Clin Cardiol       Date:  2006-01       Impact factor: 2.882

10.  The association between A1C and subclinical cardiovascular disease: the multi-ethnic study of atherosclerosis.

Authors:  Marguerite J McNeely; Robyn L McClelland; Diane E Bild; David R Jacobs; Russell P Tracy; Mary Cushman; David C Goff; Brad C Astor; Steven Shea; David S Siscovick
Journal:  Diabetes Care       Date:  2009-06-23       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.